We found higher expression of PLA2G4A in multiple myeloma patients, as well as patients with the asymptomatic premalignant stage of multiple myeloma known as MGUS, in comparison to healthy individuals. This evidence concerns the gene PLA2G4A and plasma cell myeloma.